Nogueira Renan Brito, Pires Andréa Rodrigues Cordovil, Soares Thélia Maria Santos, Rodrigues Simone Rabello de Souza, Campos Mariane Antonieta Menino, Toloi Giovanna Canato, Waisberg Jaques
Einstein (Sao Paulo). 2013 Dec;11(4):456-61. doi: 10.1590/s1679-45082013000400009.
To analyze the immunoexpression of the COX-2, p53, and caspase-3 proteins in colorectal adenomas and non-neoplastic mucosa.
72 individuals were subjected to colonoscopy, which provided 50 samples of adenomas and 45 samples of non-neoplastic colorectal mucosa. The tissue samples were obtained via the tissue microarray technique and subjected to immunohistochemical analysis using primary anti-p53, anti-COX-2, and anti-caspase-3 antibodies. The positivity and intensity of the immunoreaction were classified. The analyzed variables were as follows: site of the adenomas in the colon, degree of dysplasia, size, and score of positivity and intensity of immunoexpression of the p-53, caspase-3, and COX-2 proteins.
The immunoexpression of mutated protein p53 was positive in 30 (60%) adenoma samples and negative in 20 (40%) adenoma samples. The immunoexpression of mutated protein p53 was negative in 39 (86.6%) samples and positive in 6 (13.3%) samples of the non-neoplastic colorectal mucosa (p<0.0001). Significant differences were seen between both the largest size (p=0.006) and the highest degree of dysplasia (p<0.0001) of the adenomas and the intensity of immunoexpression of mutated protein p53. The positivity and intensity of immunoexpression of COX-2 (p=0.14) and caspase-3 (p=0.23) showed no significant differences between the adenomas and the non-neoplastic colorectal mucosa.
Mutated protein p53 was hyperexpressed in the adenomas compared with the non-neoplastic mucosa. Greater size and greater degree of dysplasia in the adenomas were associated with higher expression of mutated protein p53. The immunoexpression of COX-2 and caspase-3 in the adenomas did not exhibit a correlation with the anatomical-pathological features of the tumors and did not differ from the corresponding expression levels in the non-neoplastic mucosa.
分析环氧化酶-2(COX-2)、p53和半胱天冬酶-3(caspase-3)蛋白在大肠腺瘤及非肿瘤性黏膜中的免疫表达情况。
72例患者接受结肠镜检查,获取了50份腺瘤样本和45份非肿瘤性大肠黏膜样本。采用组织芯片技术获取组织样本,并使用抗p53、抗COX-2和抗caspase-3一抗进行免疫组化分析。对免疫反应的阳性率和强度进行分类。分析的变量如下:结肠腺瘤的部位、发育异常程度、大小以及p53、caspase-3和COX-2蛋白免疫表达阳性率和强度的评分。
突变型p53蛋白在30份(60%)腺瘤样本中免疫表达阳性,在20份(40%)腺瘤样本中免疫表达阴性。突变型p53蛋白在39份(86.6%)非肿瘤性大肠黏膜样本中免疫表达阴性,在6份(13.3%)样本中免疫表达阳性(p<0.0001)。腺瘤的最大尺寸(p=0.006)和最高发育异常程度(p<0.0001)与突变型p53蛋白免疫表达强度之间均存在显著差异。COX-2(p=0.14)和caspase-3(p=0.23)免疫表达的阳性率和强度在腺瘤与非肿瘤性大肠黏膜之间无显著差异。
与非肿瘤性黏膜相比,突变型p53蛋白在腺瘤中高表达。腺瘤更大的尺寸和更高的发育异常程度与突变型p53蛋白的更高表达相关。腺瘤中COX-2和caspase-3的免疫表达与肿瘤的解剖病理学特征无相关性,且与非肿瘤性黏膜中的相应表达水平无差异。